ABSTRACT
Coronary artery bypass grafting (CABG) is regarded as the mainstay of treatment in selected patients with coronary artery disease including those with left-main, three-vessel disease, or diabetics. Most of the retrospective studies have proven that revascularization with CABG not only ameliorates symptoms, but also contributes to the improvement of survival.
